PubMed

Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?

Sridhar GR, Thota H, Allam AR, Suresh Babu C, Siva Prasad A, Divakar Ch.

Lipids Health Dis. 2006 Nov 11;5:28.PMID: 17096857 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease.

Rao AA, Sridhar GR, Das UN.

Med Hypotheses. 2007;69(6):1272-6. Epub 2007 Jun 5.PMID: 17553629 [PubMed - indexed for MEDLINE]Related articles

Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's disease.

Huff FJ, Maire JC, Growdon JH, Corkin S, Wurtman RJ.

J Neurol Sci. 1986 Feb;72(2-3):121-9.PMID: 3711929 [PubMed - indexed for MEDLINE]Related articles

Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation.

Das UN.

Med Sci Monit. 2007 Dec;13(12):RA214-21. Review.PMID: 18049445 [PubMed - indexed for MEDLINE]Related articles

Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample.

Piccardi M, Congiu D, Squassina A, Manconi F, Putzu PF, Mereu RM, Chillotti C, Del Zompo M.

Am J Med Genet B Neuropsychiatr Genet. 2007 Oct 5;144B(7):895-9.PMID: 17503475 [PubMed - indexed for MEDLINE]Related articles

Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease.

Geula C, Darvesh S.

Drugs Today (Barc). 2004 Aug;40(8):711-21. Review.PMID: 15510242 [PubMed - indexed for MEDLINE]Related articles

Inflammation and NF-kappaB in Alzheimer's disease and diabetes.

Granic I, Dolga AM, Nijholt IM, van Dijk G, Eisel UL.

J Alzheimers Dis. 2009 Apr;16(4):809-21. Review.PMID: 19387114 [PubMed - indexed for MEDLINE]Related articles

Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment.

Tasker A, Perry EK, Ballard CG.

Expert Rev Neurother. 2005 Jan;5(1):101-6.PMID: 15853480 [PubMed - indexed for MEDLINE]Related articles

Competitive substrate inhibition in the histochemistry of cholinesterase activity in Alzheimer's disease.

Schätz CR, Geula C, Mesulam M.

Neurosci Lett. 1990 Sep 4;117(1-2):56-61.PMID: 2290622 [PubMed - indexed for MEDLINE]Related articles

Acetylcholinesterase and butyrylcholinesterase--important enzymes of human body.

Patocka J, Kuca K, Jun D.

Acta Medica (Hradec Kralove). 2004;47(4):215-28. Review.PMID: 15841900 [PubMed - indexed for MEDLINE]Related articles

Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.

Duysen EG, Li B, Darvesh S, Lockridge O.

Toxicology. 2007 Apr 20;233(1-3):60-9. Epub 2006 Dec 2.PMID: 17194517 [PubMed - indexed for MEDLINE]Related articles

[Cholinesterases and their importance in the etiology, diagnosis and therapy of Alzheimer's disease]

Patocka J, Strunecká A, Rípová D.

Cesk Fysiol. 2001 Feb;50(1):4-10. Review. Czech. PMID: 11268561 [PubMed - indexed for MEDLINE]Related articles

Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine.

Scacchi R, Gambina G, Moretto G, Corbo RM.

Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):502-7.PMID: 18780301 [PubMed - indexed for MEDLINE]Related articles

Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).

Déniz-Naranjo MC, Muñoz-Fernández C, Alemany-Rodríguez MJ, del Carmen Pérez-Vieitez M, Aladro-Benito Y, Irurita-Latasa J, Sánchez-García F.

Neurosci Lett. 2007 Oct 29;427(1):34-8. Epub 2007 Sep 4.PMID: 17923322 [PubMed - indexed for MEDLINE]Related articles

Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease.

Sáez-Valero J, Small DH.

Brain Res. 2001 Jan 19;889(1-2):247-50.PMID: 11166713 [PubMed - indexed for MEDLINE]Related articles

The ratio of acetylcholinesterase to butyrylcholinesterase influences the specificity of assays for each enzyme in human brain.

Huff FJ, Reiter CT, Rand JB.

J Neural Transm. 1989;75(2):129-34.PMID: 2918305 [PubMed - indexed for MEDLINE]Related articles

The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease.

Duysen EG, Li B, Lockridge O.

Expert Opin Drug Metab Toxicol. 2009 May;5(5):523-8. Review.PMID: 19416087 [PubMed - indexed for MEDLINE]Related articles

[Acetylcholinesterase--apoptosis induction, role in neurological diseases and leukemia]

Bukowska B.

Postepy Biochem. 2005;51(2):154-61. Review. Polish. PMID: 16209353 [PubMed - indexed for MEDLINE]Related articles

Decreased ratio of CSF acetylcholinesterase to butyrylcholinesterase activity in Alzheimer's disease.

Arendt T, Bigl V, Walther F, Sonntag M.

Lancet. 1984 Jan 21;1(8369):173. No abstract available. PMID: 6140490 [PubMed - indexed for MEDLINE]Related articles

Neuropathological and immunochemical studies of brain parenchyma in acetylcholinesterase knockout mice: implications in Alzheimer's disease.

Rice SG, Nowak L, Duysen EG, Lockridge O, Lahiri DK, Reyes PF.

J Alzheimers Dis. 2007 Jul;11(4):481-9.PMID: 17656828 [PubMed - indexed for MEDLINE]Related articles